The discovery of the ocular hypotensive effect of topically applied prostaglandins (PGs) has raised a number of questions about the mechanisms of action involved. The aim of the present thesis was to answer some of these questions. PGs reduce the intraocular pressure (IOP) by increasing uveoscleral flow through the ciliary muscle, but the exact mechanism is not known. Morphological changes may be involved. PGs are also involved in the inflammatory response. In the first study the aim was to investigate the effect of latanoprost, a prostaglandin F2 a-analogue, on the blood-aqueous barrier and the IOP restoration after long-term treatment. 26 glaucoma patients were treated with latanoprost (50 pg/ml) once daily for 6-12 months. Aqueous protein concentration was followed with a laser flare meter in 16 patients throughout this period. No change was observed. IOP increased slowly after withdrawal of treatment. It was concluded that latanoprost has no clinically significant effect on the permeability of the blood-aqueous barrier and that the IOP will return to pretreatment levels within a few weeks, indicating that any changes in the ciliary muscle morphology are reversible. In 20 healthy volunteers it was attempted to prevent the ocular hypotensive effect of latanoprost by inhibiting uveoscleral flow by a pronounced ciliary muscle contraction. For this purpose a high dose of the cholinergic agonist, physostigmine (1 drop 8 mg/ml alternate hours) was used. However, the effects on IOP of the two drugs were mainly additive most likely due to a short-lasting effect of physostigmine on the ciliary muscle. The progressive IOP reduction by physostigmine in the second study raised the question as to whether the drug reduces aqueous flow apart from enhancing outflow. On the contrary, in the third study repeated administrations of physostigmine, in 20 normal subjects, increased aqueous flow, measured with fluorophotometry, by about 25%. From studies of patients it is known that latanoprost twice daily has less ocular hypotensive effect than once daily. This was the subject of the two remaining studies. The possibility that latanoprost causes a short-lasting increase in aqueous flow was examined in 18 healthy volunteers. Application of a second drop in the morning would blunt some of the early IOP lowering effect of latanoprost. Once or twice daily applications had similar effect on aqueous flow, a tendency to an increase without any difference between the dose regimens. The next study confirmed the difference in effect on IOP between once and twice daily applications in 40 normal subjects. The difference remained even when one of the two applications was omitted after two weeks’ treatment. The results indicate that applying latanoprost twice daily induces a modest receptor desensitisation. / <p>Diss. Umeå : Umeå universitet, 1997, härtill 5 uppsatser.</p> / digitalisering@umu

This dissertation presents my efforts to use viologens to improve the performance of glucose fuel cells and aqueous redox flow batteries. These two electrochemical systems have the potential to efficiently exploit renewable sources of energy. The contributions and significance of this work are briefly described below. Glucose Fuel cells. For glucose fuel cells, viologens were adopted as an electron mediator to facilitate the transfer of electrons from glucose to electrodes for power generation. Use of a mediator circumvents the need for precious metal electrodes to catalyze glucose oxidation. Both the oxidation efficiency and rate of glucose oxidation are important to the viability of glucose fuel cells. Oxidation efficiency is defined as the extent to which the carbons of a carbohydrate (glucose for instance) are oxidized relative to full oxidation to carbon dioxide. The efficiency measured in this study depended on the initial molar ratio of viologen to glucose and also on the rate of the regeneration of the mediator. The maximum conversion efficiency observed was ~22%, which is about three times larger than the values observed for precious-metal-based fuel cells. Rate performance is another important aspect of a glucose fuel cell. Detailed simulations demonstrated that rate performance of viologen-mediated cells was limited principally by mass transfer. The maximum obtainable current density was ~200 mA/cm2, which is significantly higher than the rates available from biological fuel cells and comparable to the values observed for precious-metal-based fuel cells. Viologen-mediated fuel cells offer the potential for higher oxidation efficiency and high current densities at a significantly lower cost. This makes viologen-mediated cells an appealing option for future development of glucose fuel cells. Redox Flow Battery. An asymmetric viologen called MMV was assessed for potential use in aqueous flow batteries to improve performance. With an asymmetric structure, MMV demonstrated one of the most negative redox potentials reported to date for organic electroactive compounds. MMV also showed a relatively high solubility in neutral electrolytes. The electrochemical reaction of MMV involved a reversible single electron transfer with fast kinetics. These characteristics support MMV as a promising anolyte for flow battery applications to improve capacity, energy density, and cell potential. MMV, however, exhibited poor cycling performance at elevated concentrations since it underwent irreversible or partially reversible side reactions. Signs of dimerization and precipitation were observed during cycling. These undesired reactions can be potentially mitigated by synthesizing asymmetric MMV derivatives that possess a higher charge than that possessed by MMV (+1). This modification can reduce the extent of dimerization by increasing repulsive forces between the monomers, and it also has the potential to reduce precipitation by increasing the solubility limit of the compounds.

No description available.